BROS vs ERNA · P/E 105, rev $1.28B vs P/E 0.0, rev $582.0K
Dutch Bros Inc (BROS) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported BROS revenue for 2024-12-31 was $1.28B. Net income was $66.5M. Revenue was up 32.6% from 2023-12-31 to 2024-12-31. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
BROS currently screens at market cap $11.74B and trailing P/E 105.0. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the BROS and ERNA stock pages for the full models.
Not investment advice.